| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |